STOCK TITAN
  1. Home
  2. Sec-filings
  3. LXEO
  4. [EFFECT] Lexeo Therapeutics, Inc. SEC Filing

[EFFECT] Lexeo Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
-
-
-
-
-
Positive
  • None.
Negative
  • None.
-
-
-
-
-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 30, 2025 4:00 P.M.
Form: S-3
CIK: 0001907108
Company Name: Lexeo Therapeutics, Inc.
File Number: 333-288025

Source: View Original Filing on SEC EDGAR

Stock LXEO logo
Lexeo Therapeutics Inc

NASDAQ:LXEO

LXEO Rankings

#6748 Ranked by Market Cap
N/A Ranked by Dividends

LXEO Latest News

Jun 24, 2025
Lexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA Therapeutics
May 27, 2025
Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases
May 12, 2025
Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights
May 1, 2025
Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Apr 7, 2025
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

LXEO Latest SEC Filings

Jul 1, 2025
[424B3] Lexeo Therapeutics, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Jun 30, 2025
[Form 4] Lexeo Therapeutics, Inc. Insider Trading Activity
Jun 30, 2025
[Form 4] Lexeo Therapeutics, Inc. Insider Trading Activity
Jun 30, 2025
[Form 4] Lexeo Therapeutics, Inc. Insider Trading Activity
Jun 30, 2025
[Form 4] Lexeo Therapeutics, Inc. Insider Trading Activity

LXEO Stock Data

138.74M
28.32M
1.25%
106.47%
7.36%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
NEW YORK